| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099056 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders neuroleptic agents. |
| 07/25/2002 | US20020098271 Method for preparing a gamma-unsaturated beta-lactone and use thereof as an aromatic and flavouring ingredient |
| 07/25/2002 | DE19983487C1 Verfahren zur Herstellung von Citalopram A process for the preparation of citalopram |
| 07/25/2002 | DE10112829C1 Verfahren zur Herstellung von gereinigtem Citalopram A method for preparing purified citalopram |
| 07/25/2002 | CA2435117A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2434068A1 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2425135A1 Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
| 07/24/2002 | EP1224197A1 Hygromycin derivatives |
| 07/24/2002 | EP1224194A1 Hygromycin a prodrugs |
| 07/24/2002 | EP1224177A1 Process for preparing oxazolines from tetrahydrofurans |
| 07/24/2002 | EP1224168A1 Antifungal enediynes |
| 07/24/2002 | EP0989114B1 N,n-disubstituted amic acid derivatives |
| 07/24/2002 | EP0930296B1 Fluorinated prostaglandin derivatives and medicines |
| 07/24/2002 | EP0882701B1 Substituted amide derivatives |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360605A Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group |
| 07/24/2002 | CN1360585A Method for preparing gama-unsaturated beta-lactone and use thereof as aromatic and flavouring ingredient |
| 07/24/2002 | CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 07/24/2002 | CN1360571A Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 07/24/2002 | CN1360520A Method of producing monolithic oxidation catalysts and their use in gas phase oxidation of carbohydrates |
| 07/24/2002 | CN1360501A Treatment of neurotic disorders |
| 07/24/2002 | CN1088065C Preparation process of phthalide compound |
| 07/24/2002 | CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates |
| 07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/23/2002 | US6423850 Preparation and use of gamma-butyrolactones as cross-linking agents |
| 07/23/2002 | US6423737 Benzamidoxime prodrugs as antipneumocystic agents |
| 07/23/2002 | US6423727 Certain thiol inhibitors of endothelin-converting enzyme |
| 07/23/2002 | US6423717 Nervous system disorders |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002055478A1 Process for preparation of optically active aminolactone derivatives and intermediates of the derivatives |
| 07/18/2002 | WO2002055463A1 Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures |
| 07/18/2002 | WO2002055136A2 Intrasvascular drug delivery device and use therefor |
| 07/18/2002 | WO2002055070A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy |
| 07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2001082920A3 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | US20020095051 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 07/18/2002 | DE10101022A1 Fluorierte Aromaten und ihre Verwendung in Flüssigkristallmischungen Fluorinated aromatics and their use in liquid crystal mixtures |
| 07/18/2002 | CA2436814A1 Intravascular drug delivery device and use therefor |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2433070A1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/17/2002 | EP1223169A1 Agent for potentiating nerve growth factor activity containg 1,2-ethanediol derivate or salt thereof |
| 07/17/2002 | EP1223168A1 Method for the preparation of enantiomerically enriched amino and hydroxyfuranones |
| 07/17/2002 | EP1223154A1 Process for the preparation of sugar alcohols using a macroporous catalyst |
| 07/17/2002 | EP1223153A1 Process for the preparation of sugar alcohols using a catalyst formed in-situ |
| 07/17/2002 | EP1222184A2 Preparation and use of gamma-butyrolactones as cross-linking agents |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222181A1 Method for preparing a benzofuran or benzothiophene compound |
| 07/17/2002 | EP1222180A2 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 07/17/2002 | EP1222166A2 Novel p-aminophenols and colorants containing said compounds |
| 07/17/2002 | EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 07/17/2002 | EP1222159A2 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 07/17/2002 | EP1017481A4 Electrochemical methods for recovery of ascorbic acid |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0925278B1 Cytostatic hydroxamic acid derivatives |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | CN1359382A Method for preparing citalopram |
| 07/17/2002 | CN1359368A Aromatic esters for marking or tagging organic products |
| 07/16/2002 | US6420574 Reacting 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile with substituted alkyl halide/sulfonate; chemical intermediate converted to amine; antidepressant; avoids by-product formation |
| 07/16/2002 | US6420464 Thermosetting resin epoxy resins |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420420 Method for increasing the concentration of ascorbic acid in brain tissue of a subject |
| 07/16/2002 | US6420419 L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same |
| 07/16/2002 | US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420334 2-alkoxydecahydro-2,3a,4,4,7-pentamethyl-3,7a-methano-7ah-indeno(5,6-b)furans; etherification and cyclization of hydroxy ketone or enol ether with an alcohol; fragrances; perfumes; stabile; effective; long-lasting |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/16/2002 | CA2367610A1 A process for preparing enantiomer-enriched amino and hydroxyfuranones |
| 07/16/2002 | CA2104452C Treatment of cellulite with retinoids |
| 07/11/2002 | WO2002053551A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds |
| 07/11/2002 | WO2002053550A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053133A1 Pharmaceutical composition containing citalopram |
| 07/11/2002 | WO2002053099A2 Methods and compositions for treating periodontal disease |
| 07/11/2002 | WO2002028353A3 Phosphate transport inhibitors |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | WO2001073332A3 Pipe joint assembly and method for using same |
| 07/11/2002 | WO2001003685A3 Novel prodrugs for antimicrobial amidines |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020090388 Implantable, for sustained delivery of a drug directly into systemic circulation of an animal |
| 07/11/2002 | CA2439730A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/11/2002 | CA2432410A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220848A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |